Medicskin Holdings Ltd. (HK:8307)

:8307

8307

Medicskin Holdings Ltd.

RESEARCH TOOLSreports

Want to see HK:8307 full AI Analyst Report?

Medicskin Holdings Ltd. (8307) Price & Analysis

1 Followers

8307 Stock Chart & Stats

HK$0.17

HK$0.00(0.00%)

At close: Nov 11 4:00 PM EST

HK$0.17

HK$0.00(0.00%)

Day’s Range― - ―

52-Week RangeHK$0.02 - HK$0.24

Previous CloseN/A

Volume16.00K

Average Volume (3M)24.27K

Market Cap

HK$47.61M

Enterprise ValueHK$42.34M

Total Cash (Recent Filing)HK$25.16M

Total Debt (Recent Filing)HK$19.89M

Price to Earnings (P/E)―

Beta0.61

Next Earnings

Jun 22, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding396,736,000

10 Day Avg. Volume55,600

30 Day Avg. Volume24,266

Financial Highlights & Ratios

PEG Ratio-2.09

Price to Book (P/B)17.50

Price to Sales (P/S)1.63

P/FCF Ratio8.86

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Cash-flow ResilienceRising operating cash flow and a strong free-cash-flow-to-net-income ratio provide durable liquidity independent of accounting losses. This supports working capital, modest capex and optional deleveraging or strategic spending over the next several quarters, reducing short-term solvency risk.

Operational Efficiency (EBITDA Margin)A modest but persistent improvement in EBITDA margin signals management discipline and scalable cost control. Even small margin gains improve cash generation and provide a structural buffer that can accelerate recovery once revenue stabilizes, aiding medium-term profitability prospects.

Lean Operating StructureA small headcount implies a lean fixed-cost base and operational flexibility. Lower structural overhead enables quicker cost adjustments if revenues soften and helps preserve cash, increasing the company's ability to sustain operations and invest selectively during a multi-quarter turnaround.

Bears Say

High Financial LeverageExtremely high leverage and a thin equity cushion materially raise refinancing and interest-rate risk. This constrains strategic flexibility, increases default risk during revenue stress, and can force cash allocation to debt service instead of reinvestment, challenging medium-term stability.

Sharp Gross Margin ErosionA sustained drop in gross margin suggests structural pricing pressure or rising input costs that weaken core unit economics. Lower gross margins reduce the runway for operating leverage to restore net profitability and necessitate product, pricing or cost-structure remediation to regain durable profitability.

Revenue Contraction And Persistent LossesContinued revenue decline combined with multi-year net losses indicates weak demand or market positioning. This trend erodes equity and elevates reliance on external funding; without sustained revenue growth, the company faces mounting pressure to restore top-line momentum or secure new capital.

8307 FAQ

What was Medicskin Holdings Ltd.’s price range in the past 12 months?

Medicskin Holdings Ltd. lowest stock price was HK$0.02 and its highest was HK$0.24 in the past 12 months.

What is Medicskin Holdings Ltd.’s market cap?

Medicskin Holdings Ltd.’s market cap is HK$47.61M.

When is Medicskin Holdings Ltd.’s upcoming earnings report date?

Medicskin Holdings Ltd.’s upcoming earnings report date is Jun 22, 2026 which is in 9 days.

How were Medicskin Holdings Ltd.’s earnings last quarter?

Medicskin Holdings Ltd. released its earnings results on Nov 24, 2025. The company reported HK$0 earnings per share for the quarter, the consensus estimate of N/A by HK$0.

Is Medicskin Holdings Ltd. overvalued?

According to Wall Street analysts Medicskin Holdings Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medicskin Holdings Ltd. pay dividends?

Medicskin Holdings Ltd. pays a Notavailable dividend of HK$0.025 which represents an annual dividend yield of N/A. See more information on Medicskin Holdings Ltd. dividends here

What is Medicskin Holdings Ltd.’s EPS estimate?

Medicskin Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medicskin Holdings Ltd. have?

Medicskin Holdings Ltd. has 396,736,000 shares outstanding.

What happened to Medicskin Holdings Ltd.’s price movement after its last earnings report?

Medicskin Holdings Ltd. reported an EPS of HK$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -23.684%.

Which hedge fund is a major shareholder of Medicskin Holdings Ltd.?

Currently, no hedge funds are holding shares in HK:8307

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medicskin Holdings Ltd.

Medicskin Holdings Limited operates as an investment holding entity, specializing in the provision of medical skin care services across Hong Kong. Operating under the Medicskin brand, its centers deliver a wide array of dermatological solutions. These services tackle various skin ailments, including acne, pigmentation issues, rosacea, dermatitis, eczema, and warts. The company also focuses on aesthetic improvements, offering treatments for skin rejuvenation, facial sculpting, and body contouring. Specific procedures address concerns like acne scars, enlarged pores, the removal of unwanted moles, and permanent hair reduction. Medicskin employs advanced technologies such as dermal fillers, intense focused ultrasound, radio frequency, and a variety of laser and light-based therapies for facial contouring and other treatments. Beyond specialized procedures, it markets skincare products and provides general health management services. A significant part of its offering includes preventative health screenings, encompassing genetic tests, thorough physical examinations, laboratory analyses, diagnostic imaging, and comprehensive body check-ups. Moreover, the company extends its expertise to men's facial, skin, and body care, and administers vaccines for shingles and human papillomavirus. Founded in 2000, Medicskin Holdings Limited is based in Central, Hong Kong, and operates as a subsidiary of Topline Worldwide Limited.